Cargando…
Neurotoxin injection in benign submandibular gland hypertrophy: A first choice treatment
BACKGROUND: Various benign clinical entities with a symptomatology of hypertrophic submandibular glands like sialadenitis, sialadenosis, sialolithiasis, or an ageing neck have been described. Botulinum toxin type A is an elegant tool in the management of these conditions. METHODS: This article is an...
Autores principales: | Karapantzou, Chrisanthi, Jakob, Mark, Canis, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7178459/ https://www.ncbi.nlm.nih.gov/pubmed/32337352 http://dx.doi.org/10.1002/lio2.363 |
Ejemplares similares
-
Impaired spontaneous secretion as a potential factor in the development of sialolithiasis in the submandibular gland: A preliminary sialoscintigraphic study
por: Chen, Yen‐Chun, et al.
Publicado: (2022) -
Diagnostic value of CBCT in Chinese children with adenoid hypertrophy
por: Gao, Dekun, et al.
Publicado: (2022) -
Success of minimally invasive salivary gland surgery—Quality of life, prognostic factors
por: Weigelt, Frederike, et al.
Publicado: (2020) -
Stenting versus balloon dilatation in patients with tracheal benign stenosis: The STROBE trial
por: Marchioni, Alessandro, et al.
Publicado: (2022) -
Submandibular Gland Injury With a Ball Bearing Gunshot Wound
por: Liu, Cherry, et al.
Publicado: (2020)